Richter pharma AG Company Profile

02:11 EDT 19th June 2018 | BioPortfolio

The past four centuries have witnessed the emergence of a globally successful pharmaceutical company from a small pharmacy facing the "Stadtplatz", the central town square of Wels.Established around 1600 and still rooted in the same spot, the pharmacy has been owned by the Fritsch / Richter Family for nearly 100 years. Wels serves both as the corporate headquarters site and its departure point for the entire Austrian market. In addition, a branch in Vienna guarantees prompt and reliable service for eastern Austria.
Yet international business is also a major priority for Richter Pharma. We consequently export our own products and those of distribution partners to over forty countries, supported by subsidiaries in Australia, Bulgaria and Romania.


A - 4600


Phone: 43 (07242) 490 - 0
Fax: 43 (07242) 490 - 17

News Articles [761 Associated News Articles listed on BioPortfolio]

New prescriptions of Gideon Richter's Esyma on hold

Doctors are not to prescribe Gedeon Richter’s Esmya for uterine fibroids in the UK while European regulators carry out a safety review of the drug.

Gedeon Richter 1st-qtr sees sales and profits rising

Gedeon Richter today reported first-quarter 2018 financials, showing that consolidated sales at 113,945…

Five Questions For: Melinda Richter, Global Head at JLabs

Healthcare innovation is very personal for Melinda Richter. She was an ambitious 26-year-old, posted by a global telecom company to Beijing as part of its fast-track leadership program. “I had the e...

Biotech Analysis Central Pharma News: Allergan And Richter's Success, Sellas Life Sciences' Breast Cancer Data, Abbvie's Patent Boost

Allergan, Gedeon Richter Plan to Submit Cariprazine sNDA for Depression

Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.  

EMA issues measures to minimize liver damage risk from Richter's Esmya

(Reuters) - European Medicines Agency issued guidelines on Friday to help minimize the risk of rare but serious liver injury associated with Hungarian drugmaker Richter's Esmya.

Allergan and Gedeon Richter Eye Another Indication for Bipolar Depression Drug Cariprazine

Allergan and its developmental partner Gedeon Richter Ltd. are eying an add-on approval from the U.S. Food and Drug Administration for a depression treatment based on new Phase III data released Tuesd...

Richter’s Uterine Fibroid Drug Esmya Hit By Liver Safety Concerns In EU

EU safety restrictions relating to liver toxicity concerns are likely to lead to changes to the labeling of Richter’s uterine...    

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Isolated Richter's syndrome of the brain: diagnosis in the eye of the beholder.

How I do… sacrospinofixation following Richter technique by mini-invasive vaginal route.

Moving pharma contracting into the era of accountability.

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Rejuvenating the Face: An Analysis of 100 Absorbable Suture Suspension Patients.

Absorbable suture suspension (Silhouette InstaLift, Sinclair Pharma, Irvine, CA) is a novel, minimally invasive system that utilizes a specially manufactured synthetic suture to help address the issue...

Clinical Trials [92 Associated Clinical Trials listed on BioPortfolio]

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

This research study studies the combination of ibrutinib and obinutuzumab with or without the standard chemotherapy regimen of CHOP to see how well these drugs work in treating patients wi...

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

This research study is evaluating the combination of a study drug, venetoclax, and a standard chemotherapy regimen, EPOCH-R, as a possible treatment for Richter's Syndrome. The drugs invo...

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

The purpose of the study is to investigate whether combination of obinutuzumab, lenalidomide, and high dose methylprednisolone in the treatment of Richter's Syndrome. The study will evalua...

Study of Blinatumomab in Richter Transformation

The goal of this clinical research study is to learn if blinatumomab can help to control Richter Transformation (RT, a type of blood cancer). The safety of this drug will also be studied.

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

The goal of this clinical research study is to find the highest tolerable dose of fludarabine and cytarabine that can be given in combination with oxaliplatin and rituximab in the treatmen...

Companies [749 Associated Companies listed on BioPortfolio]

Evestra, Inc. and Gedeon Richter Plc.

Gedeon Richter Plc. (, headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western ...

Richter pharma AG

The past four centuries have witnessed the emergence of a globally successful pharmaceutical company from a small pharmacy facing the "Stadtplatz", the central town square of Wels.Established around 1...

Richter-Helm BioTec GmbH & Co. KG

"Richter-Helm is a dynamic and expanding biotechnology company located in Hamburg, Germany. The company was founded in 1997 as Strathmann Biotec and was acquired by a joint-venture of Gedeon Richter P...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "Richter pharma AG" on BioPortfolio

We have published hundreds of Richter pharma AG news stories on BioPortfolio along with dozens of Richter pharma AG Clinical Trials and PubMed Articles about Richter pharma AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Richter pharma AG Companies in our database. You can also find out about relevant Richter pharma AG Drugs and Medications on this site too.

Quick Search


Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record